CD33 and acute myeloid leukemia: To this end, NSG mice were engrafted with U973 AML cells (CD33high, CD38high, CD123low, CD135low, CD371high) and treated with AdCAR-T-cells plus AMs targeting CD33, CD38, CD123, CD135 or CD371 (Fig. 3A).